Avesthagen launches 7 botanical bioactives

39289 Investors following Cipla. Share this News with them.

0

Like this story, share it with millions of investors on M3

Avesthagen launches 7 botanical bioactives

Life-sciences company Avesthagen Ltd has launched seven botanical bioactives under the Avesta brandname targeting specific conditions like diabetes, bone-loss and cardiovascular-diseases, reports Business Line.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Villoo Morawala-Patell takes over as Chairman of Avesthagen Glenmark’s molecule GRC 4039, enters Phase I trials Sun Pharma buys Taro Pharma shares from Brandes Orchid receives US FDA approval for Cefuroxime Axetil ANDA ALSO READ See latest News about Cipla See previous management interviews See what other Experts & Brokerages are saying about Cipla Cipla BSE | NSE 25/05/12 Are Mutual Funds betting on Cipla?

Mumbai, Feb. 21:

Life-sciences company Avesthagen Ltd has launched seven botanical bioactives under the Avesta brandname targeting specific conditions like diabetes, bone-loss and cardiovascular-diseases.

For starters, the branded bio-active ingredients will be used in food-products, even as human trials are underway to launch the ingredients as prescription, pharmaceutical products a year later, said Dr Villoo Morawala Patell, Chairperson and Managing Director of Avesthagen.

The bioactives, manufactured at the company's plant near Bangalore, will be sold through the fast-moving consumer goods channel, and the pharmacy channel, said Mr Samaresh Parida, Avesthagen's Chief Operating Officer.

Contd on page 2......